AGENT FOR TREATMENT OF ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS Russian patent published in 2004 - IPC

Abstract RU 2220740 C1

FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention relates to preparing agent for treatment of allergic rhinitis and allergic conjunctivitis. Agent comprises a base and cytokines taken among the group: recombinant alpha-, beta-, gamma-interferon taken in the amount 1 000-100 000 IU per 1 g of agent; antihistaminic preparations taken among the group: diazolinum, mebhydrolin, antazoline, ebastin, loratadine, levocabastine, azelastine, astemizol, terfenadine, diphenhydramine, chloropyramine, cetirizine, promethazine taken in the amount 0.0001-0.1 g per 1 g of agent; corticosteroid preparations taken among the group: hydrocortisone, fludrocortisone, flumetasone, betamesone, mometasone, ftorcortolone, triamcinolone, prednisone, prednisolon, dexamethasone taken in the amount 0.002-0.01 g per 1 g of agent. Agent comprises additionally anti- inflammatory preparations taken among the group: sodium diclofenac, indometacin, ibuprofen, naproxen; antibacterial agent taken among the group: dioxydin, zinc sulfate, myramistin; antibiotics with broad spectrum of effect, methylbenzethonium chloride, cetylpyridonium chloride, alkyltrimethylammonium bromide, chlorhexidine gluconate, iodopovidonum, imidiazinylurea, diazolidine urea. Agent comprises also additionally regulators and stabilizers of cellular functions taken among the group: theophylline, sodium cromoglicate, sodium nedocrimal, vitamins and it comprises also vasoconstrictive preparations taken among the group: xylometazoline, naphazoline, oxymetazoline, tetryzoline, phenylephrine. As a base the agent comprises one or some components taken among the group of additions including: vaseline, glycerol, polyethylene oxide, propylene glycol, vegetable oil, essential oil, silicone oil. Invention provides the development of highly effective agent for treatment of allergic rhinitis and allergic conjunctivitis. EFFECT: improved preparing method, enhanced effectiveness and valuable medicinal properties of agent. 6 cl

Similar patents RU2220740C1

Title Year Author Number
CURATIVE AGENT 2000
  • Gaponjuk P.Ja.
  • Markov I.A.
  • Markova E.A.
  • Gaponjuk P.P.
RU2187332C1
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT 2000
  • Gaponjuk P.Ja.
  • Markov I.A.
  • Markova E.A.
  • Gaponjuk P.P.
RU2187328C1
SUPPOSITORY 2006
  • Markov Il'Ja Aleksandrovich
  • Gaponjuk Petr Jakovlevich
  • Markova Elena Alekseevna
  • Gaponjuk Polina Petrovna
RU2322968C1
CONDOM LUBRICANT 2000
  • Gaponjuk P.Ja.
  • Markov I.A.
  • Markova E.A.
  • Gaponjuk P.P.
RU2187329C1
INTRANASAL AGENT 2002
  • Gaponjuk P.Ja.
  • Markov I.A.
  • Markova E.A.
  • Gaponjuk P.P.
RU2220739C1
ANTIVIRAL MEDICATION - NASAL DROPS 2010
  • Markov Il'Ja Aleksandrovich
  • Markova Elena Alekseevna
  • Gaponjuk Polina Petrovna
  • Gaponjuk Petr Jakovlevich
RU2437676C1
MEDICATION FOR VAGINAL APPLICATION, POSSESSING CONTRACEPTIVE AND PROTECTIVE AGAINST INFECTIOUS DISEASES ACTION 2010
  • Markov Il'Ja Aleksandrovich
  • Markova Elena Alekseevna
  • Gaponjuk Polina Petrovna
RU2432961C1
ANTIVIRAL AGENT 2000
  • Gaponjuk P.Ja.
  • Markov I.A.
  • Markova E.A.
  • Gaponjuk P.P.
RU2187330C1
CO-DRUG EXHIBITING ANTIMYCOTIC, ANTIVIRAL, ANTIMICROBIAL, ANTI-INFLAMMATORY, IMMUNOMODULATING AND BACTERICIDAL ACTION FOR EXTERNAL OR LOCAL APPLICATION 2010
  • Markov Il'Ja Aleksandrovich
  • Markova Elena Alekseevna
  • Gaponjuk Polina Petrovna
RU2431497C1
ANTIVIRAL AGENT - EYE DROPS 2012
  • Markov Il'Ja Aleksandrovich
  • Markova Elena Alekseevna
  • Gaponjuk Polina Petrovna
  • Markova Inna Nikolaevna
  • Gaponjuk Petr Jakovlevich
RU2473363C1

RU 2 220 740 C1

Authors

Gaponjuk P.Ja.

Markov I.A.

Markova E.A.

Gaponjuk P.P.

Dates

2004-01-10Published

2002-08-30Filed